The High Cost of GLP Audit Failure
In the world of non-clinical safety testing, regulatory scrutiny is intensifying. The FDA’s Bioresearch Monitoring (BIMO) program conducts routine surveillance inspections of GLP facilities, and OECD member authorities conduct similar inspections under the Mutual Acceptance of Data (MAD) framework. A single significant finding can invalidate years of research, delay product approvals, and expose your organization to regulatory action, including Warning Letters and Form 483 observations.
Yet, many laboratories treat GLP audit preparation as a frantic scramble. Pulling together documents, double-checking records, and hoping inspectors do not look too closely. This reactive approach is not only stressful but also risky. The organizations that consistently pass GLP audits with flying colors share one thing in common. They have built a culture and infrastructure where compliance is a natural state of operations, not a panic-driven exercise.
Building a laboratory that is always ready for a GLP audit requires a systematic approach that touches every facet of your operations. Here is how to achieve that state of readiness.
Why Audit Readiness Must Be a Continuous State
Regulatory inspections under 21 CFR Part 58 and the OECD Principles of GLP can occur with little notice. The FDA conducts both surveillance inspections, which are routine checks of a laboratory’s compliance, and directed inspections, which are targeted investigations of specific studies or issues. In either scenario, your laboratory’s compliance posture is evaluated in real-time.
The consequences of failure are severe. FDA Warning Letters frequently cite violations such as failure of facility management to verify test article concentration and uniformity, inadequate QAU oversight, and failure to maintain proper documentation. These findings can lead to study rejection, regulatory delays, and significant financial losses.
The solution is to build a laboratory that is compliant every day, not just when an audit is announced. This requires embedding GLP principles into your daily operations and fostering a culture where every staff member understands their compliance responsibilities.
Critical Infrastructure for GLP Compliance
Your laboratory’s physical infrastructure and equipment form the foundation of GLP compliance. Regulatory agencies expect certain standards to be met consistently.
Adequate Laboratory Space
21 CFR Part 58.49 requires that testing facilities provide separate laboratory space for routine and specialized procedures, as needed. Failure to maintain proper separation of test systems or species is a common violation that can compromise data integrity and animal welfare. Laboratories must also ensure that areas are organized to prevent cross-contamination and maintain the integrity of studies.
Calibrated and Maintained Equipment
Equipment used to generate GLP data must be calibrated at defined intervals, with maintenance records readily available. Inspectors will scrutinize calibration certificates and traceability to national standards, maintenance logs and service records, and system suitability and performance verification. Equipment that is not properly calibrated can produce inaccurate data, compromising the validity of entire studies.
Validated Computerized Systems
Electronic systems that generate, manipulate, or store GLP data must be validated, with audit trails enabled and access controls in place. A common pitfall is assuming that electronic systems are automatically compliant. They are not. Without validated audit trails, version control, and backup procedures, electronic records can be worse than paper from a data integrity perspective.
The Critical Role of Personnel and Training
Your staff are your greatest asset in maintaining GLP compliance. They are also your greatest vulnerability if not properly trained and supervised. Key requirements include up to date job descriptions defining GLP responsibilities, documented training records for all personnel, clear designation of Study Directors and Principal Investigators for multi-site studies, and continuous training on updated SOPs and regulatory requirements.
The Study Director serves as the single point of control for each study and holds ultimate responsibility for its scientific conduct and GLP data integrity. They ensure the approved study plan is followed, deviations are justified, and raw data are accurately recorded and traceable. Ultimately, they are accountable for the proper conduct of the study and for ensuring that the final report reflects the data generated.
Quality Assurance Unit Independence
The QAU is the sentinel of GLP compliance, but only if it operates with genuine independence from study conduct. QA personnel operate independently from study conduct, including from the Study Director, to verify GLP compliance through scheduled inspections, audits, and report reviews.
Regulatory agencies have identified common QAU violations that laboratories must avoid. These include QAU personnel participating in studies they inspect, QAU reporting to Study Directors rather than senior management, and insufficient QAU resources leading to superficial inspections.
An effective QAU must conduct study-based inspections, facility-based inspections, and process-based inspections to verify compliance at all levels. The QAU must also perform protocol and final report reviews, ensuring that reports accurately reflect the raw data generated during the study.
Documentation: The ALCOA+ Foundation
Data integrity is the bedrock of GLP compliance. Regulatory agencies worldwide use the ALCOA+ framework to assess data trustworthiness. Data must be attributable, meaning every data point must identify who generated it, when, and on what system. Data must be legible throughout its retention period. Data must be recorded at the time of the activity, not hours or days later. Data must be original, representing the first recording or a certified true copy. Data must be accurate with verified calculations and consistent units. Data must also be complete, consistent, enduring, and available, with no deleted data without justification, no contradictions, durable storage, and accessible archives.
Documentation failures are among the most common FDA 483 observations. Common errors include corrections that obscure original entries such as white-out or overwriting, missing signatures or dates, failure to document deviations, and data recorded on loose notes before being transcribed to official records. Every study begins with an approved written plan. All raw data must be recorded promptly and legibly, and any modification must remain traceable to demonstrate ongoing GLP compliance.
How GxP Cellators Can Help You Build an Audit-Ready Laboratory
At GxP Cellators, we understand that building an audit-ready laboratory requires more than just checking boxes. It demands a comprehensive approach to compliance that touches every aspect of your operations. With over 500 GLP audits successfully completed, our certified GLP and IRCA auditors bring global expertise to help you achieve and maintain GLP compliance.
Our team includes certified professionals with RQAP-GLP and IRCA Auditor certifications, ensuring that our auditing methodologies comply with international standards for management systems and technical compliance. We offer end-to-end GLP auditing services for non-clinical GLP studies, ensuring compliance with OECD guidelines and 21 CFR Part 58.
Our services include gap assessments, readiness audits, mock inspections, and full GLP compliance audits. We perform GLP audits on behalf of clients and sponsors, providing objective, third-party evaluations that carry greater credibility with regulatory authorities.
Our global presence spans Saskatchewan, Calgary, Toronto, North Carolina, Indiana, and Frankfurt, enabling us to deploy auditors worldwide and understand local regulatory nuances while upholding the OECD framework.
Our track record speaks for itself. With over 500 GLP audits completed, we have helped laboratories across the globe achieve and maintain GLP compliance. Our findings are factual, evidenced, and actionable. We do not close an audit until we see objective evidence that corrective actions work.
Are you ready to build a laboratory that is always prepared for a GLP audit? Partner with GxP Cellators to achieve GLP compliance with confidence.
Reach out to us today to schedule your GLP audit.
Email:
Phone: +1 (306) 715-9460
Website: /gxp-auditing/
GxP Cellators – Your Certified GLP Audit Partners
